Хронический гистиоцитарный интервиллузит как причина невынашивания беременности и антенатальной гибели плода

1. Михалев С.А., Курцер М.А., Радзинский В.Е., Оразов М.Р., Печникова В.В., Кудрявцев Г.Ю., Кудрявцева Я.Ю., Михалёва Л.М. Патология плаценты при преждевременных родах: систематизация морфологических повреждений. Вопросы гинекологии, акушерства и перинатологии. 2026; 25(2): 32-42. https://dx.doi.org/10.20953/1726-1678-2026-2-32-42 [Mikhalev S.A., Kurtser M.A., Radzinsky V.E., Orazov M.R., Pechnikova V.V., Kudryavtsev G.Yu., Kudryavtseva Ya.Yu., Mikhaleva L.M. Placental pathology in preterm birth: systematization of morphological lesions. Gynecology, Obstetrics and Perinatology. 2026; 25(2): 32-42 (in Russian). https://dx.doi.org/10.20953/1726-1678-2026-2-32-42].
2. Щеголев А.И., Серов В.Н. Клиническая значимость поражений плаценты. Акушерство и гинекология. 2019; 3: 54-62. https://dx.doi.org/10.18565/aig.2019.3.54-62 [Shchegolev A.I., Serov V.N. Clinical significance of placental lesions. Obstetrics and Gynecology. 2019; (3): 54-62. https://dx.doi.org/10.18565/aig.2019.3.54-62].
3. Низяева Н.В. Гистологические критерии воспалительных изменений ворсинчатого дерева плаценты. Международный журнал прикладных и фундаментальных исследований. 2018; 2: 202-7. [Nizyaeva N.V. Histological criteria for inflammatory changes in the villous tree of the placenta. International Journal of Applied and Fundamental Research. 2018; 2: 202-7 (in Russian)].
4. Moar L., Simela Ch., Nanda S., Marnerides A., Al-Adnani M., Nelson-Piercy C. et al. Chronic histiocytic intervillositis (CHI): current treatments and perinatal outcomes, a systematic review and a meta-analysis. Front. Endocrinol. (Lausanne). 2022: 13: 945543. https://dx.doi.org/10.3389/fendo.2022.945543
5. Cornish E.F., McDonnell T., Williams D.J. Chronic inflammatory placental disorders associated with recurrent adverse pregnancy outcome. Front. Immunol. 2022: 13: 825075. https://dx.doi.org/10.3389/fimmu.2022.825075
6. Zhang X., Fang Z., Wang X. Gaps in maternal-fetal interface rejection response: chronic histiocytic intervillositis. Front. Immunol. 2025; 16:1625701. https://dx.doi.org/10.3389/fimmu.2025.1625701
7. Ghotbi E., Mansouri Z., Azarboo A., Eshraghi N., Ghaemi M., Haddadi M. et al. Placental chronic histiocytic intervillositis: pregnancy outcomes and complications, a systematic review and meta-analysis. Int. J. Gynecol. Pathol. 2026; 45(3): 228-34. https://dx.doi.org/10.1097/PGP.0000000000001148
8. Bos M., Koenders M.J.M., Dijkstra K.L., van der Meeren L.E., Nikkels P.G. J., Bloemenkamp K.W.M. et al. The severity of chronic histiocytic intervil-lositis is associated with gestational age and fetal weight. Placenta. 2023: 131: 28-35. https://dx.doi.org/10.1016/j.placenta.2022.11.014
9. Mawa A., Bizet G., Stichelbout M., Devisme L., Pauchet M., Gobert S. et al. Caracteristics of women presenting with chronic histiocytic intervillositis during pregnancy: a case-control study. J. Gynecol. Obstet. Hum. Reprod. 2025; 54(2): 102882. https://dx.doi.org/10.1016/j.jogoh.2024.102882
10. Gavillet M., Gengler C., Legardeur H., Gannagé M., Puder J., Beauport L. et al. Case report: a novel approach to prevent chronic histiocytic intervillositis and recurrent pregnancy loss by targeting maternal alloimmunity. Front. Immunol. 2025; 16: 1693016. https://dx.doi.org/10.3389/fimmu.2025.1693016
11. Albersammer L., Leon J., Martinovic J., Dagobert J., Lebraud E., Bessières B. et al. Histologic and molecular features shared between antibody-mediated rejection of kidney allografts and chronic histiocytic intervillositis support common pathogenesis. J. Pathol. 2025; 266(2): 177-91. https://dx.doi.org/10.1002/path.6413
12. Shangaris P., Martín Monreal M.T. Maternal–foetal immune rejection: parallels between placental CHI and allograft rejection. J. Pathol. 2025; 267(2): 121-5. https://dx.doi.org/10.1002/path.6459
13. Bell-Ricketts M.J., Porter-Wright I.A., Borovika K., Bowman A., Lombardi G., Nicolaides K.H. et al. Chronic histiocytic intervillositis: Insights into immunopathogenesis and prospective treatments. J. Reprod. Immunol. 2026; 175: 104886. https://dx.doi.org/10.1016/j.jri.2026.104886
14. Abisror N., Cheloufi M., Cohen J., Coulomb A., McAvoy Ch., Fain O. et al. Intravenous immunoglobulins for recurrent chronic histiocytic intervillositis: a series of case studies. Am. J. Reprod. Immunol. 2024; 92(1): e13898. https://dx.doi.org/10.1111/aji.13898
15. Brady C.A., Williams C., Batra G., Church E., Tower C.L., Crocker I.P. et al. Immunomodulatory therapy reduces the severity of placental lesions in chron-ic histiocytic intervillositis. Front. Med. (Lausanne). 2021; 8: 753220. https://dx.doi.org/10.3389/fmed.2021.753220

Поступила 21.09.2026

Принята в печать 07.10.2026